Wird geladen...
Target Therapy in Hematological Malignances: New Monoclonal Antibodies
Apart from radio- and chemotherapy, monoclonal antibodies (MoAbs) represent a new, more selective tool in the treatment of hematological malignancies. MoAbs bind with the specific antigens of the tumors. This interaction is a basis for targeted therapies which exhibit few side effects and significan...
Gespeichert in:
| Veröffentlicht in: | Int Sch Res Notices |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Hindawi Publishing Corporation
2014
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4897146/ https://ncbi.nlm.nih.gov/pubmed/27433507 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/701493 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|